Your browser doesn't support javascript.
loading
Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma.
Garg, Abhishek D; Vandenberk, Lien; Van Woensel, Matthias; Belmans, Jochen; Schaaf, Marco; Boon, Louis; De Vleeschouwer, Steven; Agostinis, Patrizia.
  • Garg AD; Cell Death Research & Therapy (CDRT) Lab, Department of Cellular and Molecular Medicine, KU Leuven University of Leuven, Leuven, Belgium.
  • Vandenberk L; Laboratory of Pediatric Immunology, Department of Microbiology and Immunology, KU Leuven University of Leuven, Leuven, Belgium.
  • Van Woensel M; Research Group - Experimental Neurosurgery & Neuroanatomy, KU Leuven University of Leuven, Leuven, Belgium.
  • Belmans J; Laboratoire de Pharmacie Galenique et Biopharmacie, ULB, Bruxelles, Belgium.
  • Schaaf M; Laboratory of Pediatric Immunology, Department of Microbiology and Immunology, KU Leuven University of Leuven, Leuven, Belgium.
  • Boon L; Cell Death Research & Therapy (CDRT) Lab, Department of Cellular and Molecular Medicine, KU Leuven University of Leuven, Leuven, Belgium.
  • De Vleeschouwer S; Bioceros BV, the Netherlands.
  • Agostinis P; Research Group - Experimental Neurosurgery & Neuroanatomy, KU Leuven University of Leuven, Leuven, Belgium.
Oncoimmunology ; 6(4): e1295903, 2017.
Article en En | MEDLINE | ID: mdl-28507806
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2017 Tipo del documento: Article